Delhi Cracks Down on Pharmacy Discount Claims, Cites Consumer Protection

The Drugs Control Department in Delhi has issued fresh guidelines directing pharmaceutical retailers to discontinue deceptive discount advertising practices that have become commonplace across the city's pharmacy sector. The move follows concerns that exaggerated claims of price reductions—some as high as 80 percent—mislead consumers about actual savings and medication availability.

According to the department's directive, pharmacies remain permitted to offer genuine discounts on medicines sold below the maximum retail price (MRP) set by manufacturers. However, such promotions must be transparent, clearly communicating the actual final price to consumers rather than emphasizing percentage reductions that may not reflect real savings.

The distinction between legitimate pricing and deceptive advertising has become increasingly important as online and offline pharmacies intensify competition. The department clarified that discounts reflecting genuine commercial practices do not violate regulations, but marketing claims must accurately represent the terms of sale and avoid creating false impressions about product availability or pricing structures.

Pharmacies that fail to comply with the directive risk facing regulatory action. The Drugs Control Department has emphasized that the guidelines align with consumer protection objectives while maintaining the commercial viability of the pharmacy sector. The department stated that compliance will be monitored through routine inspections and consumer complaint mechanisms.